NCT01276678View on ClinicalTrials.gov

Multi-Analyte, Genetic, and Thrombogenic Markers of Atherosclerosis

UnknownOBSERVATIONAL

Enrollment

1,300

Participants

Timeline

Start Date

June 30, 2010

Primary Completion Date

June 30, 2014

Study Completion Date

December 31, 2014

Conditions

Coronary Artery Disease

Trial Locations (1)

21215

RECRUITING

Sinai Center for Thrombosis Research, Baltimore

Sponsors

Lead Sponsor

LifeBridge Health

Collaborators (1)

Nanosphere, Inc.

All Listed Sponsors

collaborator

Accumetrics, Inc.

INDUSTRY

collaborator

Nanosphere, Inc.

INDUSTRY

lead

LifeBridge Health

OTHER

NCT01276678 - Multi-Analyte, Genetic, and Thrombogenic Markers of Atherosclerosis | Biotech Hunter | Biotech Hunter